Material
M ycobacterium tuberculosis is a leading global health concern causing 1.4 million deaths in 2011 (1) . A small percentage of infected individuals do not generate an initial protective response and progress to primary disease within 2 y, whereas 90% of immunocompetent people are able to control infection, often for life. Although a vaccine (bacillus Calmette-Guérin) is widely administered, it does not provide adequate immunity against infection or disease. Various animal models and human studies have demonstrated that certain cytokines, including IFN-g, TNF, and IL-12, as well as CD4 and CD8 T cells and activated macrophages are essential for protection against tuberculosis (2) .
Initiation of the immune response against M. tuberculosis infection is a slow process. In humans, very little is known about the events that occur during transmission and initial stages of infection, because these events are "silent." Exposure is likely to be to a very small numbers of organisms, and in some settings, it is probable that it is repeated exposure that results in successful transmission events.
Animal studies demonstrated that the microbe is inhaled into the airways where it encounters alveolar macrophages and dendritic cells (DC), which transport bacteria to draining lymph nodes for the purpose of priming T cells (3, 4) . These primed T cells migrate back to the infected lung to participate in granuloma formation, but the lymph nodes also remain infected. Studies have demonstrated that after low-dose aerosol infection of mice, M. tuberculosis bacilli appear in the lymph node between days 9 and 11, with variation among even inbred mice; bacteria in lymph nodes are necessary to initiate a priming response (4) . A recent study (5) using mice without appreciable lymph nodes suggested that priming of T cells can also occur in the lung. In normal mice, bacteria arrive in the spleen 2-3 wk postinfection, and this is also a potential site for priming T cells. Using adoptive transfer systems with large numbers of M. tuberculosis Ag-specific transgenic T cells, priming of T cells in lymph nodes (as determined by CD69 expression) occurred between days 11 and 12, but significant T cell proliferation in the lymph nodes began only at day 14 (6) . T cell responses can be detected in the lungs by ∼2 wk postinfection (p.i.), and by 4 wk p.i., bacterial growth in lungs is stabilized (7) ; the level of bacilli in lungs remains at high levels for months as the mouse experiences progressive chronic tuberculosis. This relatively long period of time between infection and induction of T cell responses may allow M. tuberculosis to gain a foothold in the lungs without facing an adaptive immune response (4) . This was also observed in a computational model of the immune response in lungs to M. tuberculosis (8) . Understanding factors involved in priming of T cells in response to M. tuberculosis infection may improve our ability to design vaccines that enhance rapid recall responses in the lungs and lymph node to improve protection against disease.
Our previous studies in CD40 2/2 mice indicated that a 2-to 3-fold higher aerosol inoculum resulted in an increase of IFN-gproducing cells in the lymph node by 3 wk and in the lungs at 4 and 5 wk, thus improving survival of these mice (9) . This suggested that Ag or bacterial load could influence priming of T cells in the lymph nodes. Two other studies, using adoptive transfer of transgenic T cells, demonstrated that the numbers of bacilli within the draining lymph nodes were positively correlated with robustness of priming (as defined by activation and proliferation of the transgenic T cells) (6, 10) . The studies were conflicting in their findings of effects of inoculum size on timing of priming: one study supported that a higher inoculum could cause earlier priming of T cells (6) ; however, effects were minimal even though large inocula (1200 CFU via aerosol) were used. The other study showed an effect of dose on magnitude of responses but not on timing of induction (10) .
In the current study, we addressed the influence of inoculum size on timing and magnitude of T cell priming in lymph nodes in a naive mouse model without transfer of transgenic T cells to determine how normal naive frequencies of M. tuberculosis Ag-specific T cells respond to different doses of infection. We integrated mathematical modeling of the priming response in lymph nodes with our experimental data and determined that, in an intact mouse, there was minimal effect of inoculum size on priming in the lymph node and only a modest effect on the M. tuberculosis-specific number of T cells in the lung. There were, however, higher bacterial numbers and total cell numbers (including T cells) in mice with higher inocula compared with those inoculated with fewer bacteria. We addressed three hypotheses for these observed increases using wetlaboratory and modeling approaches. Our mathematical modeling approach predicts additional factors, such as a key role for IL-10 and DCs in regulating T cell priming in the lymph node and in driving effector T cell numbers in the lung in a high-dose scenario.
Materials and Methods
Aerosol infection of mice C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) were aerosol infected with M. tuberculosis (H37Rv or Erdman strain) using a flat chamber aerosolizer (In-Tox Products, Moriarty, NM). A low dose of 8 3 10 5 -3 3 10 6 /ml or a high dose of 8 3 10 6 -3 3 10 7 /ml in the nebulizer was used to deliver 10-40 or 130-550 CFU, respectively, to the lung as determined by plating whole-lung homogenates from four to six mice per group on 7H10 agar (Difco, Sparks, MD) 24 h after aerosolization. Colonies were counted after incubation of plates for 21 d at 37˚C and 5% CO 2 . The experiments were performed six times, using different doses and timing of necropsies. Representative data are provided in this study. Mice were kept under specific pathogen-free conditions in a biosafety level 3 facility, and all studies were approved by the University of Pittsburgh Institutional Animal Care and Use Committee.
Single-cell suspensions and flow cytometry
Whole lungs and lymph nodes were crushed, and single-cell suspensions were obtained as described previously (11) . Live cells were counted by trypan blue exclusion and 5 3 10 5 cells were washed in FACS buffer (13 PBS and 0.01% BSA; SerCare Life Sciences, Milford, MA). The following cell surface Abs were added in staining buffer (FACS buffer, 20% mouse serum [Gemini Bio-Products, West Sacramento, CA]), anti-CD69 (clone H1.2F3), anti-CD11b (clone M1/70), anti-GR-1 (clone RB6-8CS), anti-CD4 (clone RM4-5), and anti-CD8 (clone 53-6.7) from BD Biosciences (San Diego, CA) and anti-CD11c (clone N418) from eBioscience (San Diego, CA). MHC class I GAP tetramer (recognizing the GAPINSATAM amino acids of Rv0125) (Beckman Coulter, Fullerton, CA, and NIH Tetramer Facility, Atlanta, GA) and MHC class II multimer ESAT-6 (recognizing aa 1-20 (MTEQQWNFAGIEAAASAIQG) (M. Jenkins, University of Minnesota, Minneapolis, MN, and NIH Tetramer Facility) were also added at 1:67 or 1:100 (respectively) final concentration. Cells were incubated with Abs for 30 min at room temperature then washed with FACS buffer and fixed in 2% paraformaldehyde (Sigma-Aldrich, St. Louis, MO). Samples were collected using an LSRII flow cytometer (BD Biosciences) and analyzed with FlowJo (Tree Star, Ashland, OR). A table summarizing these data is included as Supplemental Table I and is a representative experiment characterizing cell types in the lung.
Colony-forming units
Bacterial counts were determined by serial dilution of lung and lymph node homogenates from mice at various time points postinfection. Dilutions were plated onto 7H10 agar (Difco) and incubated at 37C, 5% CO 2 for 21 d.
IFN-g production by ELISPOT assay
IFN-g was measured by ELISPOT assay. Bone marrow-derived DCs used as APCs in the assay were generated as described previously (7) . DCs were either infected with M. tuberculosis overnight prior to stimulation of T cells in the ELISPOT assay, or ESAT-6 peptides were added 1 h prior to addition of T cells.
Ki67 staining for proliferation
Cell surface staining was performed as above with ESAT-6 multimer and GAP tetramer, anti-CD69, anti-CD4, and anti-CD8 Abs, as described previously. After a 1-h incubation, cells were then washed with FACS buffer and fixed in 2% paraformaldehyde and 23 APO active fixative (Cell Technology, Mountain View, CA) for 20 min to overnight at room temperature. Cells were washed twice in 13 PBS, resuspended in 100 ml 1% saponin (EMD Chemicals, Gibbstown, NJ), and 20 ml anti-Ki67 (clone B56) from BD Biosciences. Cells were incubated for 60 min at room temperature, then washed twice in 1% saponin/13 PBS, 13 in 2% BSA/ 13 PBS, and resuspended in 1% paraformaldehyde. Samples were collected using an LSRII flow cytometer (BD Biosciences, San Jose, CA) and analyzed with Flowjo (Tree Star, Ashland, OR).
Statistical analysis
Data were compared among high-and low-dose mice at each time point. Mann-Whitney analysis was used for flow cytometry data, and Student t test was used for log-transformed CFU data and ELISPOT data. Analyses were performed in Prism (GraphPad) or Excel (Microsoft), including the linear regression analyses. Mean and SD is shown in each figure.
Mathematical model
We developed a series of mathematical models that qualitatively and quantitatively characterize the cellular and cytokine network during infection in lung and lymph node (12, 13) . In this study, we used our most recent generation, two-compartment mathematical model of lung and lymph node dynamics (13) to capture the behavior of T cell priming in lymph nodes and T cell migration to lungs during M. tuberculosis infection. The model was built on our experimental data generated in normal mice. A mathematical modeling approach allows us to address a number of questions that are challenging to address in an in vivo system, and because this model was built on data from immune competent C57BL/6 mice infected with different inocula, it is directly relevant to our studies here. The model captures the dynamics of many cell types, such as macrophage (resting; infected; classical; and alternatively activated [AAM]), DC (immature [IDC], Ag-bearing, or mature [MDC]) and lymphocyte populations in both lung and lymph node (naive, precursor, and effector CD4 and CD8 T cells). Table I lists the T cell phenotypes used in the model (macrophages not shown, for a full explanation of model, see Ref. 13 ). We also model four cytokine concentrations (TNF, IFN-g, IL-10, and IL-12) in both lymph node and lung compartments. Details of the nonlinear ordinary differential equation system are shown in Ref. 13 . Fig. 1 shows a diagram of the main immune mechanisms captured in the two-compartment mathematical model.
The model describes macrophage recruitment, infection, activation and death (by age, apoptosis, bursting, and cytotoxic T cell killing). DC mechanisms captured in the model are recruitment, maturation, trafficking to the lymph node, and death (by age). DCs become mature after bacterial uptake and they are the only cell types that migrate to the lymph node upon maturation. We also describe mechanisms of T cell recruitment, differentiation, proliferation, migration, and death (by apoptosis and age), both in lung and lymph node. To exactly replicate experimental conditions, we use data on CFU dynamics as input functions for the model in the lung and lymph node. Details on how the input functions are calculated and implemented are shown in Ref. 13 .
Uncertainty and sensitivity analysis
To further investigate the impact of inocula dose on priming dynamics, we performed uncertainty and sensitivity analyses (US/A) on simulations generated after varying the dose of infection. This method allows us to determine the amount of variability in the system and also which mechanisms predominately induce it. More generally, we seek to identify immune mechanisms that affect a change in priming and/or effector cell numbers in lung and lymph node during infection with M. tuberculosis. Uncertainty analysis is performed by an extensive and efficient statistical sampling of the parameter space called Latin hypercube sampling (LHS) scheme. We use a generalized correlation coefficient called partial rank correlation coefficient (PRCC) to correlate changes in immune mechanisms as well as Ag dose to some key readouts of the system, for example, the magnitude of primed (in the lymph node) and effector (in the lung) CD4 and CD8 T cells. Details and applications of these techniques in systems biology can be found in Ref. 14.
We perform a detailed uncertainty analysis on the model by varying ∼100 parameters within ranges based on baseline scenarios described in Ref. 13 . We use a sample size of 3000, with uniform a priori probability distributions for each unknown parameter. The mathematical model simulates 30 d p.i. to match the experimental data. We then calculate PRCCs, focusing on T cell priming in the lymph node and on number of effector T cells in the lung. For the purpose of the analysis, we label all the effector T cells in the lymph node as primed T cells and all the effector T cells in the lung as effector T cells. The results are grouped by T cell phenotype and physiological compartment (lung or lymph node) and are all shown in Tables II and III . We also looked at what mechanisms can impact total cell numbers in the lung.
Results
Higher inocula results in higher bacterial numbers in lymph node and lung but higher cell numbers only in the lungs C57BL/6 mice were infected via aerosol with M. tuberculosis (Erdman strain) (Fig. 1) . Inoculum dose was modulated by the concentration of bacteria placed in the nebulizer; exposure time in the aerosolizer was kept constant. In this experiment, one group was exposed to a low dose of 2.7 3 10 6 /ml and the other group a high dose of ∼2.4 3 10 7 /ml in the nebulizer. At day 1, four mice per group were harvested to determine actual dose of bacteria delivered to the lung. The low-dose mice received an average of 20 6 5 CFU, and the high-dose mice received an average of 555 6 150 CFU in the lungs. Mice were harvested at early time points (four mice per group at days 9, 14, 18, 22, 25, and 28 p.i.). Mice infected with the higher inoculum had significantly higher bacterial burdens at 14 and 28 d in the lymph nodes ( Fig. 2A) . In the lungs, bacterial numbers were 10-fold higher in the group with the higher inoculum at every time point sampled through 28 d ( Fig. 2A) . In a separate experiment, mice were followed to 14 wk and those infected with a higher inoculum maintained significantly higher bacterial burdens in the lungs (data not shown).
Total cell numbers upon homogenization were counted in the lung and lymph node using trypan blue exclusion; most of the living cells were lymphocytes or of monocytic lineage. No difference in total cell numbers was seen in the lymph nodes between the mice inoculated with low-or high-dose M. tuberculosis, but after 3 wk, there were significantly more cells in lungs of mice inoculated with the higher dose. (Fig. 2B ) These findings were consistent across six separate experiments with different inocula, with low dose defined as ,130 CFU and high dose as .130 CFU; matched low-and high-dose groups were inoculated with ∼10-fold differences in CFU.
IFN-g production in lungs, but not lymph node, is associated with inoculation dose M. tuberculosis infection results in the presence of IFN-g-producing T cells in the lung by 3-4 wk p.i. in mice (7) . If an inoculation dose were a factor in priming immune responses to M. tuberculosis, we would expect an increase in IFN-g-producing T cells in lymph nodes in mice that received a higher inoculum, because more bacteria (and therefore Ag) should increase priming and cytokine-producing T cells. This should then cause a subsequent increase in IFN-g-producing cells in the lungs. By IFN-g ELISPOT, lymph node cells from mice infected with a low or high dose had similar frequencies of M. tuberculosis-specific IFN-g responses from T cells (Fig. 3) . In contrast, in high-dose infected mice, there was a higher frequency of IFN-g-producing T cells in lungs between 3 and 14 wk p.i. (Fig. 3) , compared with low-dose infected mice. For this assay, we stimulated lung and lymph node cells with either M. tuberculosis-infected DCs (Fig. 3A) or DCs pulsed with ESAT-6 peptides (Fig. 3B) . Although there were higher responses to the M. tuberculosis-infected DCs, the pattern was similar when ESAT-6 peptides were used.
ELISPOT relies on stimulation of T cells for 2 d and may provide additional signals for T cell differentiation and cytokine production ex vivo; thus, one may be measuring the potential for cells to produce cytokines, rather than the status of cytokine production in the tissue. To assess the T cell populations more directly, we used flow cytometry and fluorescent-tagged M. tuberculosis Ag-specific tetramers for T cells recognizing ESAT-6 and Rv0125 (i.e., GAP) (11) to characterize M. tuberculosis-specific CD4 and CD8 T cells (Fig. 4) . Ki67 and CD69 were markers used to assess proliferation and activation, respectively (Figs. 5, 6 ). Intracellular cytokine staining to assess TNF, IFN-g, and IL-2 production by specific T cells in response to ESAT-6 and Rv0125 was also performed (data not shown). Unexpectedly, no differences in the frequency of ESAT6 + CD4 cells and GAP + CD8 cells in the lung or lymph node were observed between mice inoculated with high or low dose (Fig. 4A) . In terms of actual numbers of ESAT-6 + CD4 and GAP + CD8 T cells, there were no differences in the lymph node; in lungs, there were more of these specific T cells in the high-dose animals at days 22 and 25 (Fig. 4B) , reflecting increased numbers of overall cells. No dose-dependent differences were observed in the functions (cytokines) of ESAT-6-or GAP-specific T cells in the lungs or lymph nodes by intracellular cytokine staining (data not shown). We also stimulated with anti-CD3/anti-CD28 Abs to assess total cells capable of producing cytokines and again found no differences between mice infected with high or low dose (data not shown) in terms of function of responding cells.
Proliferation of T cells is similar between high and low dose infection mice in lungs and lymph nodes
Although there appeared to be no dose-related response in terms of numbers of cells or priming in the lymph nodes, there were more cells, including T cells, in the lungs by 3 wk p.i. in the high-dose group compared with the low-dose group. There are at least three possibilities that could account for this increase: increased migration from lymph node to lung, increased proliferation of T cells in the lungs, or decreased cell death, all possibly related to Ag load. We addressed these possibilities by integrating our math modeling and mouse experimental approaches (Table I) . We tested whether increased proliferation could account for the increases using the mouse model, whereas we tested increased recruitment and decreased cell death with the mathematical model. To assess proliferation in the lymph nodes and lungs, Ki67, a nuclear Ag expressed in actively cycling cells, but not in resting G0 cells (15) , was measured on T cells by flow cytometry. ESAT6 + CD4 T cells expressing Ki67 in the lymph node increased from day 14 to day 18, with another increase in proliferation at day 25 (Fig. 5A) . Although the percentage of ESAT-6-specific cells that were proliferating was between 3 and 8%, these dynamic changes were mirrored when the entire CD4 T cell population in the lymph node was assessed, which had much higher proliferation. ESAT-6 + CD4 T cell proliferation peaked at day 14 in the lungs, with 60% of ESAT-6 + CD4 T cells staining positively for Ki67 and decreased to ∼20% by day 21. Although the pattern of Ki67 + M. tuberculosis-specific CD4 T cells was different between the lung and the lymph node, there were no differences among mice inoculated with low or high dose in either tissue.
Proliferation of GAP + CD8 T cells was also low in the lymph nodes; overall, CD8 T cell proliferation was lower than CD4 T cells, but inoculum dose did not affect the proliferation. In lungs, the percentage of GAP + CD8 T cells in the lungs peaked in the high-dose mice at day 14 but not until day 18 in the low-dose mice (Fig. 5B ) but returned to 20% by day 21 in both groups. Therefore, increased proliferation is not responsible for the increase in cell numbers in the lungs.
Activation of T cells is increased by inoculum dose in lungs but not lymph node
CD69 expression has been used as a marker for early activation. Previously published data using mice where large numbers of transgenic T cells were adoptively transferred suggested that a higher dose of infection caused a faster and more robust priming of T cells in the lymph nodes, based primarily on CD69 expression (6) . However, in our unmanipulated mouse model, there was no dependence on inoculum dose in frequency of CD69 + CD4 (Fig.  6A ) or CD8 T cells (Fig. 6B) , either in the total population or in M. tuberculosis-specific T cells (Fig. 6C, 6D ) in the lymph node, except at day 25. However, the frequency of activated M. tuberculosis-specific T cells was higher than the activation of the total T cell population (Fig. 6C, 6D ). In the lung, high-dose mice had significantly higher percentages of CD69 + CD4 T cells at day 25 (Fig. 6A) and of CD69 + CD8 T cells at days 14 and 25 (Fig. 6B ) compared with low-dose infection mice. In the lung, the total number of activated CD4 T cells (ESAT-6 specific and nonspecific) from the high-dose mice increased over time and are significantly higher than in low-dose mice at days 21 and 25 p.i. (Supplemental Fig. 1 ). The total number of activated CD8 T cells (GAP-specific and nonspecific) from the high-dose group also increases over time and is significantly higher at every time point than the low-dose group. There was no difference in the lymph node total number of lymph node CD69 + CD4 or CD8 T cells (both specific and nonspecific) at any time point examined (Supplemental Fig. 1 ). In our unmanipulated mouse model, we do not see a dose-dependent difference in priming of T cells based on CD69 expression. 
Increased migration could explain higher cell numbers in lungs in the high-dose infection group
In an effort to explain the increased number of total cells measured experimentally in the lung during a high-dose scenario, we used our mathematical model to test whether increased inocula have a significant impact on cell death, T cell proliferation, or cell recruitment. We used a baseline trajectory that fits our experimental data and varied only the dose (as a forcing function). We grouped together all the mechanisms captured in the mathematical model that affect cell death and cell killing in the lung, namely TNF-induced apoptosis of macrophages and T cells, Fas/Fas ligand-induced apoptosis of macrophages, cytotoxic killing, and bursting of macrophages. Our analysis indicates that inoculum dose does have a marginal effect on cell death/killing in the lung. We predict that increased inocula result in increased, and not decreased, level of /ml and the high group (n = 20) 2.7 3 10 7 /ml. The average day 1 CFU was 40 in the low-dose group and 550 in the high-dose group. This experiment was independently performed four times, with representative data shown here. Statistical significance was determined by a Mann-Whitney t test; *p , 0.05. /ml. The average day 1 CFU was 40 in the low-dose group and 550 in the high-dose group. This experiment was independently performed four times, and a representative experiment is shown here. Statistical significance was determined by a Mann-Whitney t test; *p , 0.05. increased cell numbers to three different mechanisms, namely cell death/killing, cell recruitment and cell proliferation. Recruitment is by far the most important mechanism in driving cell numbers in the lung (as determined by comparing the total fluxes of cells to the lung because of either recruitment, killing/death, and proliferation; Fig. 7B ), where cell death/killing and T cell proliferation are influencing total cell numbers in week 1 (death/killing ∼ 13%, mainly for macrophages) and weeks 2 and 3 p.i. (T cell proliferation ∼ 10%), respectively. Higher doses result in higher cell recruitment and death/killing in the first 10 d p.i., likely driving the higher total cell numbers in the lung later during infection.
No correlation between CFU and M. tuberculosis-specific T cells
We studied whether a correlation exists between bacterial numbers and numbers of M. tuberculosis-specific CD4 and CD8 T cells in the lymph nodes and lungs from individual mice, regardless of dose of infection or time point, to determine whether bacterial numbers were affecting T cell priming. There was no correlation with bacterial numbers in the lymph nodes of individual mice with either ESAT-6 + CD4 T cells (Fig. 8A) or GAP + CD8 T cells (Fig. 8B ) in those same mice, which does not support an influence of inoculum on priming of specific T cells. There was a very modest correlation in the lungs between bacterial load and specific CD4 and CD8 T cells.
Mathematical modeling can replicate adoptively transferred transgenic T cell experiments
We used our mathematical model (13) to address the differences in our experimental findings compared with published data on adoptively transferred transgenic T cells that show an effect of inoculum size on priming of T cells in the lymph node, either in terms of timing or magnitude. The goal was to recapitulate in silico those experiments where adoptively transferred transgenic T cells were injected into mice prior to challenge (with pools of up to 5 3 10 6 transgenic T cells). In those mouse experiments, inoculum dose did increase priming in lymph nodes (6, 10) . To observe an effect of inoculation dose on priming (Fig. 7C, 7D) , we had to increase in the model the rates at which CD4 and CD8 T cells are primed (a.k.a. the priming probabilities of both naive CD4 Ts [k 14 ; Fig. 7C ] and naive CD8 Ts [k 17 ; Fig. 8D ] in the model) by ∼10-fold from model baseline values (estimated in Ref. 13 to match experimental data from our unmanipulated mice). Thus, the mathematical model is able to recapitulate the adoptively transferred transgenic T cells experiments (6, 10), accommodating the effect of higher cognate frequencies of naive cells (e.g., ESAT-6 + CD4 T cells or GAP + CD8 T cells) by increasing priming probabilities that eventually influence T cell priming in lymph nodes in a dose-dependent manner.
Modeling predicts a key role for IL-10 and DCs in T cell priming and in driving effector T cell numbers
We then used the tested mathematical model to explore additional factors that could affect T cell priming in the lymph node and effector T cell numbers in the lungs to help explain the increase of cells in the lungs by 3 wk p.i. in the high-dose infected mice compared with the low-dose infected mice, seen experimentally. Our uncertainty and sensitivity results are shown in detail in Tables  II and III . List of all the lymphocyte phenotypes represented in the ordinary differential equations (ODEs) system capturing lunglymph node dynamics as described in Ref. 13 . Measure units are number of cells in the whole organ (lung or lymph node). The variable labels are shown in square brackets to help the reader in cross-referencing all the model details illustrated in Ref. 13. Modeling analyses of our two-compartment model predict two mechanisms that have a strong impact on T cell priming (in lymph node) and on effector T cell numbers (in lung), regardless of Ag dose and T cell type (CD4 or CD8). The first mechanism predicted by the model is the rate of bacterial uptake by, and maturation of, IDCs in the lung (k 12 ; Table II , positive correlation). The second mechanism predicted is the rate at which resident/resting macrophages differentiate into alternatively activated macrophages in the lymph node (k 7a ; Table II , negative correlation), although the latter affects primarily an increase in CD8 T cells. Both mecha- 2 values are lower in the lymph node than the lung. There does not seem to be a difference in priming in the lymph node as seen by M. tuberculosis-specific CD4 and CD8 T cells; this does not support the hypothesis that priming in the lymph node is dose dependent. Lines on the graphs are fitted by linear regression. R 2 represents the goodness of fit, and p value represents the significance of slope from non-zero.
Higher rates of IDC uptake/maturation increase Ag-bearing DC (MDC) numbers in the lung and induce higher rates of migration of MDCs to the lymph node. In contrast, a higher rate of AAM activation in the lymph node (k 7a ) likely increases IL-10 concentrations (AAMs are a major producer of IL-10). More IL-10 in the lymph node has a dual negative impact on priming: the first effect is direct by reducing the proliferation of CD4 and CD8 precursor effector T cells (namely, precursor Th1 and precursor CTL) (17) , whereas the second one is indirect by decreasing/delaying DC maturation (as shown in Refs. 16 and 17) .
Overall, the model predicts that IL-10 plays a key regulatory role in priming during a high Ag dose scenario. This is consistently observed for both CD4 and CD8 T cell priming in the lymph node, as well as for effector CD4 and CD8 T cell numbers in the lung. Two IL-10-related mechanisms are significantly affecting priming and effector T cell numbers (Table III) : 1) regulation of DC maturation rates in the lung (i.e., half-saturation of IL-10 concentration on DC maturation in the lung, hs I10-DC ) and 2) regulation of precursor Th1 proliferation rates in the lymph node (i.e, half-saturation of IL-10 concentration on precursor Th1 proliferation in the lymph node, hs I10-T0LN ). By decreasing regulation rates of DC maturation or precursor Th1 proliferation, a negative impact on priming occurs for both CD4 and CD8 T cells in lymph nodes, as well as on effector T cell numbers in lung (Fig. 7C , Table III ). We postulate that this occurs primarily in a high-dose inoculation scenario, because more initial uptake by and subsequent infection of AAMs occurs. Increased AAM infection results in a further boost toward an IL-10-dominated environment, which slows down DC maturation as well as T cell proliferation. Alternatively, IL-10 related mechanisms do not affect priming and effector T cell numbers in a low-dose scenario. At low Ag doses (Table III) , only CD8 + T cells are affected, and the mechanisms predicted as significant are in the lymph node and pertain to the efficiency of CD4 T cell priming by an MDC (k 14 ) and the rate of Tables II and III bacterial uptake by immature DCs and consequent DCs maturation in the lymph node (k 12a ).
Overall, IL-10 concentration is positively correlated with dose. AAM development is initially positively correlated with dose, then at approximately day 35-40, the correlation becomes increasingly negative on a very fast time scale (data not shown). This suggests that day 35 could be the switching time for an AMM-dominated to a classically activated macrophage-dominated lung environment (18) .
Discussion
Priming of T cells and migration of those cells to the site of M. tuberculosis infection is crucial for preventing primary tuberculosis. Previous studies in mice indicated that the numbers of bacilli infecting a host could influence the strength or timing of initiation of the T cell response against this pathogen (4, 6, 9, 10) . In this study, we sought to address this issue in an unmanipulated mouse model, to determine whether inoculum dose could affect priming of T cell responses in lymph nodes in the presence of the normal but low frequency of naive precursor T cells. Our data support that within a 10-to 50-fold range, inoculum size had little effect on priming of M. tuberculosis-specific T cell responses in the lymph nodes. However, in the lungs, higher infection inocula resulted in an overall increase in numbers of immune cells, a modest increase in M. tuberculosis-specific T cells, and higher bacterial numbers. A mathematical model of the lymph nodes and lung during M. tuberculosis infection in a mouse (13) provided support for the experimental data, and identified migration of T cells to the lungs in response to higher infection and Ag load as the major contributor to increased numbers of these cells in the lungs seen experimentally.
It was surprising that an increased inocula, which results in more bacteria in the lungs, and more bacteria at the early time points (days 9-14) in the draining lymph nodes, did not result in increased priming of T cells in the lymph nodes. Higher bacterial numbers translates to more Ag in the lymph nodes, which should increase priming of T cells. Our modeling data provides a possible answer to this conundrum, in that IL-10, induced by higher inocula, is predicted to suppress priming. Thus, the higher Ag levels in high-dose infected mice, which would increase priming, is balanced out by higher IL-10 levels, which inhibits priming of T cells; the net result is a level of T cell priming that is similar to that seen in low dose infected animals. In the low dose scenario, IL-10 was not a factor in the priming of T cells.
The role of IL-10 is difficult to confirm in an animal model, because IL-10 can only be present or absent (e.g., in a gene knockout mouse, or by Ab-mediated neutralization). IL-10 2/2 mice have enhanced IFN-g responses early in the lungs (19, 20) , although specific effects on priming in the lymph node were not addressed. Depending on the mouse strain, the lack of IL-10 signaling results in reduced bacterial numbers in the lungs (21) . In an in vivo system, it is difficult to assess effects of IL-10 on T cell priming independently of other previously reported IL-10-mediated responses. Thus mathematical models can identify and help clarify the roles of more complex interactions such as with IL-10 (22). We also used the mathematical model to address why our results differ from previously published studies (6, 10) . It was reported that increased inocula led to increased T cell priming in lymph nodes. However, these studies were performed by adoptively transferring large numbers of naive M. tuberculosis Ag-specific transgenic CD4 T cells prior to infection, and analysis of transferred T cells. In contrast, our studies were performed by examining native populations of T cells that were induced upon infection. Transfer of transgenic T cells greatly increases (10,000-to 1,000,000-fold) the precursor frequency of CD4 T cells. Although this certainly makes it easier to detect specific responses using flow cytometry, it may also skew the responses seen. To address whether increasing the precursor frequency could lead to an effect of inoculum dose on priming, we used our mathematical model. This model validation step was designed to show the power of our in silico representation recapitulating the transgenic T cells transfer experiment described in (6, 10) . We showed how the model can capture a dose-dependent impact on T cell priming by increasing the priming probabilities of both naive CD4 Ts (k 14 ) and naive CD8 (k 17 ) Ts: these probabilities are proxies for many mechanisms related to Ag presentation and priming, one of which is cognate frequency. Thus, higher priming probabilities captures a scenario where transgenic ("cognate") T cells are present in the system and the mathematical model successfully reproduced the dose-dependent transgenic T cells transfer experiment results, where priming becomes sensitive to Ag dose.
In summary, our data support that although inoculum dose of M. tuberculosis does not substantially influence T cell priming in the a lymph nodes, it does affect cell numbers and bacterial burden in the lungs. It is possible that in a vaccinated host, a higher dose challenge may more quickly recall T cell responses to the lungs, because in that setting priming of new T cells is less important. Thus, in vaccine challenge models, it is important to replicate a low-dose challenge, since humans are likely exposed to low levels of M. tuberculosis (often repeatedly), rather than large inocula.
